SCHEMBL15315530

SCHEMBL15315530

Cc1cc(-c2cc(C)cc(-c3ccc4c(c3)sc3ccccc34)c2)cc(-c2ccc3c(c2)sc2ccccc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
MAPT P10636 6/20 0.50
RAB9A P51151 4/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
GPR3 P46089 1/20 0.50
L3MBTL1 Q9Y468 4/20 0.36
POLB P06746 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALOX5 P09917 1/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15315528 0.97 ALDH1A1 (0.47) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL15315524 0.97 ALDH1A1 (0.47) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL23240752 0.96 ALDH1A1 (0.55) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL18960990 0.95 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL25491438 0.95 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL15315581 0.91 GPR3 (0.61) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL15315579 0.91 GPR3 (0.61) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL32665658 0.89 GPR3 (0.50) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL15315584 0.89 GPR3 (0.58) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL19001867 0.88 ALDH1A1 (0.49) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10944061-B2 Organic electroluminescent element and compound UDC IRELAND LIMITED (IE) 2021-03-09 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10944061-B2 Organic electroluminescent element and compound POU2F2, DDT, LEF1 ALDH1A1 1094/4885MAPT 713/4885RAB9A 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.